InvestorsHub Logo
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

Re: None

Tuesday, 01/27/2015 2:14:40 PM

Tuesday, January 27, 2015 2:14:40 PM

Post# of 23979
KBIO - Their director for clinical development in oncology presented this morning at PMWC15 about KB4000, their PHII drug being developed for the treatment of hematologic malignancies.

FWIW, I've been averaging down and I still think this is way undervalued.

All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.